Avalo Therapeutics, Inc.

The table below shows Avalo Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Avalo Therapeutics, Inc. reported annual revenue of $59.00K for fiscal year 2025. That is down 86.6% from $441.00K in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $1.15M (FY 2016) to $59.00K. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.